Literature DB >> 2744070

Paracetamol disposition and metabolite kinetics in patients with chronic renal failure.

L F Prescott1, G C Speirs, J A Critchley, R M Temple, R J Winney.   

Abstract

The disposition of paracetamol following an oral dose of 1.0 g was compared in 10 healthy volunteers, 7 patients with moderate chronic renal failure and 6 patients with end stage renal failure on maintenance haemodialysis. Paracetamol absorption was normal in the patients with renal failure. The mean plasma half-life of paracetamol from 2 to 8 h was similar in the 3 groups (2.1 to 2.3 h) but from 8 to 24 h it disappeared much more slowly in the renal failure patients (half-life 11.7 compared with 4.9 h in the healthy volunteers). Plasma concentrations of paracetamol glucuronide and sulphate conjugates were greatly increased in the patients with moderate renal failure and the mean plasma half-lives were 30.5 and 21.8 h respectively compared with about 3 h in the healthy volunteers. Plasma concentrations of these metabolites were even higher in the dialysis patients and there was no significant fall over 24 h. The cysteine and mercapturic acid conjugates of paracetamol could only be measured in plasma in the patients with renal failure and concentrations were very low. The fractional urinary recovery of paracetamol and its glucuronide, sulphate, cysteine and mercapturic acid conjugates was similar in healthy volunteers and patients with moderate renal failure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744070     DOI: 10.1007/bf00558162

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Data point weighting in pharmacokinetic analysis: intravenous paracetamol in man.

Authors:  J A Clements; L F Prescott
Journal:  J Pharm Pharmacol       Date:  1976-09       Impact factor: 3.765

2.  Renal tubular transport of paracetamol and its conjugates in the dog.

Authors:  G G Duggin; G H Mudge
Journal:  Br J Pharmacol       Date:  1975-07       Impact factor: 8.739

3.  Is biliary excretion of paracetamol significant in man?

Authors:  K S Jayasinghe; C J Roberts; A E Read
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

4.  Plasma half-life of clofibric acid in renal failure.

Authors:  E M Faed; E G McQueen
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

5.  Tricyclic antidepressant and metabolite levels in chronic renal failure.

Authors:  J A Lieberman; T B Cooper; R F Suckow; H Steinberg; M Borenstein; R Brenner; J M Kane
Journal:  Clin Pharmacol Ther       Date:  1985-03       Impact factor: 6.875

6.  Oxazepam disposition in uremic patients.

Authors:  I Odar-Cederlöf; J Vessman; G Alván; F Sjöqvist
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-01

7.  Dosage adjustment in renal insufficiency.

Authors:  G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

Review 8.  Drug metabolites in renal failure: pharmacokinetic and clinical implications.

Authors:  R K Verbeeck; R A Branch; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

9.  Massive propranolol metabolite retention during maintenance hemodialysis.

Authors:  W J Stone; T Walle
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

10.  Pharmacokinetics of acetaminophen elimination by anephric patients.

Authors:  D T Lowenthal; S Oie; J C Van Stone; W A Briggs; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1976-03       Impact factor: 4.030

View more
  14 in total

1.  Perturbation of paracetamol urinary metabolic ratios by urine flow rate.

Authors:  J O Miners; N J Osborne; A L Tonkin; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

2.  Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-31       Impact factor: 2.441

3.  Pharmacokinetics of intravenous paracetamol in elderly patients.

Authors:  Antti Liukas; Kristiina Kuusniemi; Riku Aantaa; Petri Virolainen; Mikko Niemi; Pertti J Neuvonen; Klaus T Olkkola
Journal:  Clin Pharmacokinet       Date:  2011-02       Impact factor: 6.447

4.  The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure.

Authors:  U Martin; R M Temple; R J Winney; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 5.  The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings.

Authors:  Garry G Graham; Michael J Davies; Richard O Day; Anthoulla Mohamudally; Kieran F Scott
Journal:  Inflammopharmacology       Date:  2013-05-30       Impact factor: 4.473

6.  Characterizing the Effects of Race/Ethnicity on Acetaminophen Pharmacokinetics Using Physiologically Based Pharmacokinetic Modeling.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

7.  The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis.

Authors:  U Martin; R M Temple; R J Winney; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations.

Authors:  Angela Villiger; Cordula Stillhart; Neil Parrott; Martin Kuentz
Journal:  AAPS J       Date:  2016-04-08       Impact factor: 4.009

9.  Population Pharmacokinetic Modeling of Acetaminophen Protein Adducts in Adults and Children.

Authors:  Sibo Jiang; Kumpal Madrasi; Tanay Samant; Chakradhar Lagishetty; Valvanera Vozmediano; Angela Chiew; Susan M Abdel-Rahman; Laura P James; Stephan Schmidt
Journal:  J Clin Pharmacol       Date:  2019-12-04       Impact factor: 2.860

10.  Ontogeny of Hepatic Sulfotransferases and Prediction of Age-Dependent Fractional Contribution of Sulfation in Acetaminophen Metabolism.

Authors:  Mayur K Ladumor; Deepak Kumar Bhatt; Andrea Gaedigk; Sheena Sharma; Aarzoo Thakur; Robin E Pearce; J Steven Leeder; Michael B Bolger; Saranjit Singh; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2019-05-17       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.